OBJECTIVE
To investigate the impact of systemic inflammation-based prognostic markers on overall survival in relapsed/refractory metastatic colorectal cancer (mCRC) patients.
METHODS
To investigate prognostic markers in mCRC patients, this study was performed with patients who have experienced